Citadel Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$216K Sell
57,426
-104,815
-65% -$395K ﹤0.01% 4929
2025
Q1
$735K Sell
162,241
-122,687
-43% -$556K ﹤0.01% 3606
2024
Q4
$2.01M Buy
284,928
+109,237
+62% +$772K ﹤0.01% 2596
2024
Q3
$1.43M Buy
175,691
+16,399
+10% +$133K ﹤0.01% 2785
2024
Q2
$1.02M Sell
159,292
-48,797
-23% -$312K ﹤0.01% 3017
2024
Q1
$1.57M Sell
208,089
-33,619
-14% -$253K ﹤0.01% 2721
2023
Q4
$2.24M Buy
241,708
+161,124
+200% +$1.49M ﹤0.01% 2304
2023
Q3
$816K Buy
80,584
+66,681
+480% +$675K ﹤0.01% 3249
2023
Q2
$174K Sell
13,903
-458,744
-97% -$5.73M ﹤0.01% 4516
2023
Q1
$5.52M Sell
472,647
-389,814
-45% -$4.55M ﹤0.01% 1734
2022
Q4
$9.17M Sell
862,461
-123,976
-13% -$1.32M ﹤0.01% 1366
2022
Q3
$9.57M Buy
986,437
+132,866
+16% +$1.29M ﹤0.01% 1319
2022
Q2
$12.4M Buy
853,571
+380,036
+80% +$5.51M ﹤0.01% 1125
2022
Q1
$12.4M Buy
473,535
+454,723
+2,417% +$11.9M ﹤0.01% 1247
2021
Q4
$746K Sell
18,812
-15,396
-45% -$611K ﹤0.01% 4164
2021
Q3
$1.71M Sell
34,208
-37,139
-52% -$1.86M ﹤0.01% 3185
2021
Q2
$3.96M Sell
71,347
-24,867
-26% -$1.38M ﹤0.01% 2428
2021
Q1
$4.5M Sell
96,214
-106,209
-52% -$4.97M ﹤0.01% 2220
2020
Q4
$8.81M Buy
202,423
+19,335
+11% +$842K ﹤0.01% 1350
2020
Q3
$6.7M Buy
183,088
+172,501
+1,629% +$6.31M ﹤0.01% 1321
2020
Q2
$309K Buy
10,587
+1,764
+20% +$51.5K ﹤0.01% 3781
2020
Q1
$230K Buy
+8,823
New +$230K ﹤0.01% 3984
2019
Q4
Sell
-56,687
Closed -$1.79M 4819
2019
Q3
$1.79M Buy
+56,687
New +$1.79M ﹤0.01% 2458